Ivneet Bhullar
Partner at Fusion Fund
San Francisco Bay Area
Overview
Work Experience
Partner
2021 - Current
Early-stage (Seed/Series A) investing in Healthcare, Enterprise & Industrial Technologies Investments: SafeBeat Rx, Meomind, Synaptec Health, Ruby Bio, Cosm Medical (Board Member), Rhino Health (Board Member), Nimble Science (Board Member), OverT Bio
Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.
Board Member
2023
Board Member
2022
Rhino Health develops a federated compute platform for privacy-preserving artificial intelligence applications.
Raised $16,049,999.00 from TELUS Ventures.
Board Member
2022
Senior Manager, Strategy & Business Development, Digital Health & Innovation
2020 - 2021
Manager, Strategy & Business Development, Digital Health & Innovation
2019 - 2020
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Fellow
2017 - 2019
Early-stage startup consulting with: • Gel4Med (Fall 2018) • Analytical Space (Spring 2018) • BrainSpec (Fall 2017)
A highly competitive leadership development program comprised of exceptional graduate students at top universities
Associate, Healthcare M&A
2018 - 2018
Lazard is a financial advisory and asset management firm focused on income strategies, alternative investments, and private equity funds.
Raised $400,000,000.00.
Operations
2015 - 2017
Procurement, Supply Chain, Quality, and Corporate Engineering.
Genentech specializes in genetic testing and personalized medicine.
Science & Engineering
2014 - 2015
Genentech specializes in genetic testing and personalized medicine.
Graduate Research Associate
2013 - 2015
Teaching Assistant
2013 - 2014
Education
Master of Business Administration - MBA
2017 - 2019
Master of Science (MS)
2013 - 2015
Bachelor of Science (BS)
2009 - 2013